Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05116202
Title A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

melanoma

Therapies

RO7247669

Atezolizumab + MTIG7192A

Ipilimumab + Nivolumab

MTIG7192A + RO7247669

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.